Exponent Stock Rises on Strong Earnings, GuruFocus Undervaluation View

Exponent's 52-week trading range is $51.91 to $81.95, with the current price at $66.85 suggesting it sits mid-range and may have room to move within its annual band.
In Q2 2026, Exponent posted EPS of $0.60 (adjusted) versus a $0.55 consensus, a positive surprise of about 9.09%.
Q2 2026 revenue reached $148.86 million, beating the consensus by 3.34%, reinforcing a pattern of strong quarterly results.
The same Q2 report notes that the prior quarter (Q1 2026) delivered EPS of $0.59 on $148.86 million in revenue, beating expectations by about 5.36%.
Exponent Inc. (EXPO) shares jumped 3.5% to $66.85 on July 31, 2026, even as analysts argue the stock is still a bargain. According to GuruFocus, the company's GF Value — a measure of fair worth — sits at $92.52, implying about 27.7% upside from the current price.
The move higher came on the heels of a strong Q2 2026 earnings report. Exponent beat EPS estimates by $0.05, posting $0.60 adjusted versus a $0.55 consensus, and topped revenue forecasts for the fourth straight quarter, according to Watchlist News.
Exponent posted Q2 2026 revenue of $148.86 million, beating the consensus estimate by 3.34%, per Watchlist News. EPS came in at $0.60 adjusted, a 9.09% positive surprise. The company cited strong demand for user research tied to artificial intelligence-enabled products as a key growth driver.
The earnings call, detailed in a transcript from GuruFocus, was led by Joni Konstantelos, Exponent's managing director. Management pointed to AI-related services as a core reason for double-digit revenue and earnings growth in the quarter.
At $66.85, Exponent trades well below its GF Value of $92.52, according to GuruFocus. The stock's 52-week range runs from $51.91 to $81.95, putting the current price squarely in the middle of its annual band. That leaves room to move in either direction.
The valuation case gets stronger when you look at history. Exponent's 5-year median price-to-earnings ratio is 46.0x. Today it trades near 30.0x. That gap suggests the stock may be cheap relative to where it has typically been priced.
Exponent raised its 2026 net revenue growth view to 9%-10%, according to Seeking Alpha, as demand tied to AI expands. That upgrade is a meaningful signal. It shows management is confident the AI-driven tailwind is not slowing down.
Analysts also expect fiscal 2026 revenue reimbursement growth of roughly 8%-10%. The company has now beaten earnings estimates for four consecutive quarters, building a track record that tends to attract longer-term investors looking for consistency.
Not everything points up. Insiders sold $1.1 million worth of EXPO shares over the past three months, per GuruFocus. Insider selling does not always mean trouble, but it is a signal investors tend to watch closely, especially when weighing a buy decision.
EXPO has also lagged the S&P 500 by about 5% so far this year. That underperformance, combined with insider activity, gives some investors pause. The key near-term question is whether management's guidance on future growth will be strong enough to close the gap.
Publishers
14
Articles
28
Reach
42